FDAAA Safety Labeling Powers Are Invoked Selectively But Leave Drugmakers Little Room To Maneuver
Executive Summary
FDA is being selective about when it invokes its authority under the Food and Drug Amendments Act of 2007 to require drug and biologic manufacturers to make safety-related label changes; however, when the agency does choose to act, industry has few options.